Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut
Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.
Teva Pharmaceuticals saw shares rise during Thursday's session after announcing its growth strategy. Richard Francis, president and CEO of Teva Pharmaceuticals, joined Cheddar News to discuss its pipeline of products that the company expects to help revenue.
Brian Jacobsen, chief economist with Annex Wealth Management, joined Cheddar News to discuss the positive sessions for the stock market as investors were optimistic of a debt ceiling deal ahead of the June 1 deadline.
The Walt Disney Co. says it's scrapping plans to build a new campus in central Florida and relocate 2,000 employees from Southern California to work in digital technology, finance and product development.
